Use of adenovirus proteins to enhance the transfection activity of synthetic gene delivery systems

Current Opinion in Molecular Therapeutics

Volumn 4, Issue 4, 2002, Pages 306-312

  Carlisle, Robert C ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Adenovirus; Gene delivery; Hexon; Penton; Polyethylenime; Polylysine

Indexed keywords

ADENOVIRUS VECTOR; ARGINYLGLYCYLASPARTIC ACID; CHLOROQUINE; COAT PROTEIN; HYBRID PROTEIN; INTEGRIN; LIPOFECTAMINE; PLASMID DNA; SYNTHETIC DNA; VIRUS DNA; VIRUS PROTEIN;

CELL NUCLEUS; CYTOPLASM; DNA PACKAGING; ENDOSOME; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; INTRACELLULAR TRANSPORT; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN DNA BINDING; PROTEIN FUNCTION; REVIEW; VIRAL GENE DELIVERY SYSTEM; VIRUS CELL INTERACTION;

ADENOVIRIDAE; ANIMALS; DNA; HUMANS; INTEGRINS; PROTEIN BINDING; RODENTIA; TRANSDUCTION, GENETIC; VIRAL PROTEINS;

ADENOVIRIDAE; DNA VIRUSES; SYNTHETIC CONSTRUCT;

EID: 0036705546     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. v integrins in adenovirus cell entry and gene delivery. Microbiol Mol Biol Rev (1999) 63:725-734.
2. Greber UF, Willetts M, Webster P, Helenius A: Stepwise dismantling of adenovirus 2 during entry into cells. Cell (1993) 75:477-486.
3. Greber UF, Webster P, Weber J, Helenius A: The role of the adenovirus protease on virus entry into cells. EMBO J (1996) 15:1766-1777.
4. Pronk R, van der Vliet PC: The adenovirus terminal protein influences binding of replication proteins and changes the origin structure. Nucleic Acids Res (1993) 21:2293-2300.
5. Wang K, Guan T, Cheresh DA, Nemerow GR: Regulation of adenovirus membrane penetration by the cytoplasmic tail of integrin β5. J Virol (2000) 74:2731-2739.
6. Seth P, Willingham MC, Pastan I: Binding of adenovirus and its external proteins to Triton X-114. Dependence on pH. J Biol Chem (1985) 260:14431-14434.
7. Seth P: Adenovirus-dependent release of choline from plasma membrane vesicles at an acidic pH is mediated by the penton base protein. J Virol (1994) 68:1204-1206.
8. Greber UF, Singh I, Helenius A: Mechanisms of virus uncoating. Trends Microbiol (1994) 2:52-56.
9. Greber UF: Virus assembly and disassembly: The adenovirus cysteine protease as a trigger factor. Rev Med Virol (1998) 8:213-222.
10. Cotten M, Weber JM: The adenovirus protease is required for virus entry into host cells. Virology (1995) 213:494-502.
11. Suomalainen M, Nakano MY, Keller S, Boucke K, Stidwill RP, Greber UF: Microtubule-dependent plus- and minus end-directed motilities are competing processes for nuclear targeting of adenovirus. J Cell Biol (1999) 144:657-672.
12. Leopold PL, Kreitzer G, Miyazawa N, Rempel S, Pfister KK, Rodriguez-Boulan E, Crystal RG: Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum Gene Ther (2000) 11:151-165.
13. Saphire AC, Guan T, Schirmer EC, Nemerow GR, Gerace L: Nuclear import of adenovirus DNA in vitro involves the nuclear protein import pathway and hsc70. J Biol Chem (2000) 275:4298-4304.
14. Niewiarowska. J, D'Halluin JC, Belin MT: Adenovirus capsid proteins interact with HSP70 proteins after penetration in human or rodent cells. Exp Cell Res (1992) 201:408-416.
15. Greber UF, Suomalainen M, Stidwill RP, Boucke K, Ebersold MW, Helenius A: The role of the nuclear pore complex in adenovirus DNA entry. EMBO J (1997) 16:5998-6007.
16. Trotman LC, Mosberger N, Fornerod M, Stidwill RP, Greber UF: Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat Cell Biol (2001) 3:1092-1100.
17. Pronk R, Stuiver MH, van der Vliet PC: Adenovirus DNA replication: The function of the covalently bound terminal protein. Chromosoma (1992) 102:S39-S45.
18. Fisher KD, Stallwood Y, Green NK, Ulbrich K, Mautner V, Seymour LW: Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene Ther (2001) 8:341-348.
19. Douglas JT, Rogers BE, Rosenfeld ME, Michael SI, Feng M, Curiel DT: Targeted gene delivery by tropism-modified adenoviral vectors. Nat Biotechnol (1996) 14:1574-1578.
20. Oupicky D, Ogris M, Howard KA, Dash PR, Ulbrich K, Seymour LW: Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. Mol Therapy (2002) 5:463-472.
21. Fisher KD, Ulbrich K, Subr V, Ward CM, Mautner V, Blakey D, Seymour LW: A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression. Gene Ther (2000) 7:1337-1343.
22. Fender P, Ruigrok RW, Gout E, Buffet S, Chroboczek J: Adenovirus dodecahedron, a new vector for human gene transfer. Nat Biotechnol (1997) 15:52-56.
23. Schoehn G, Fender P, Chroboczek J, Hewat EA: Adenovirus 3 penton dodecahedron exhibits structural changes of the base on fibre binding. EMBO J (1996) 15:6841-6846.
24. Bal HP, Chroboczek J, Schoehn G, Ruigrok RW, Dewhurst S: Adenovirus type 7 penton purification of soluble pentamers from Escherichia coli and development of an integrin-dependent gene delivery system. Eur J Biochem (2000) 267:6074-6081.
25. Medina-Kauwe LK, Kasahara N, Kedes L: 3PO, a novel nonviral gene delivery system using engineered Ad5 penton proteins. Gene Ther (2001) 8:795-803.
26. Medina-Kauwe LK, Maguire M, Kasahara N, Kedes; L: Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins. Gene Ther (2001) 8:1753-1761.
27. Hart SL, Harbottle RP, Cooper R, Miller A, Williamson R, Coutelle C: Gene delivery and expression mediated by an integrin-binding peptide. Gene Ther (1995) 2:552-554.
28. Harbottle RP, Cooper RG, Hart SL, Ladhoff A, McKay T, Knight AM, Wagner E, Miller AD, Coutelle C: An RGD-oligolysine peptide: A prototype construct for integrin-mediated gene delivery. Hum Gene Ther (1998) 9:1037-1047.
29. Carlisle RC, Read ML, Wolfert MA, Seymour LW: Self-assembling poly-L-lysine/DNA complexes capable of integrin-mediated cellular uptake and gene expression. Colloids Surfaces B: Biointerfaces (1999) 16:261-272.
30. Buckley CD, Pilling D, Henriquez NV, Parsonage G,Threlfall K, Scheel-Toellner D, Simmons DL, Akbar AN, Lord JM, Salmon M: RGD peptides induce apoptosis by direct caspase-3 activation. Nature (1999) 397:534-539.
31. Scott ES, Wiseman JW, Evans MJ, Colledge WH: Enhanced gene delivery to human airway epithelial cells using an integrin-targeting lipoplex. J Gene Med (2001) 3:125-134.
32. Aoki Y, Hosaka S, Kawa S, Kiyosawa K: Potential tumor-targeting peptide vector of histidylated oligolysine conjugated to a tumor-homing RGD motif. Cancer Gene Ther (2001) 8:783-787.
33. Erbacher P, Remy JS, Behr JP: Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther (1999) 6:138-145.
34. Muller K, Nahde T, Fahr A, Muller R, Brusselbach S: Highly efficient transduction of endothelial cells by targeted artificial virus-like particles. Cancer Gene Ther (2001) 8:107-117.
35. Colin M, Harbottle RP, Knight A, Kornprobst M, Cooper RG, Miller AD, Trugnan G, Capeau J, Coutelle C, Brahimi-Horn MC: Liposomes; enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells. Gene Ther (1998) 5:1488-1498.
36. Colin M, Maurice M, Trugnan G, Kornprobst M, Harbottle RP, Knight A, Cooper RG, Miller AD, Capeau J, Coutelle C, Brahimi-Horn MC: Cell delivery, intracellular trafficking and expression of an integrin-mediated gene transfer vector in tracheal epithelial cells. Gene Ther (2000) 7:139-152.
37. Larkin JM, Donzell WC, Anderson RG: Potassium-dependent assembly of coated pits: New coated pits form as planar clathrin lattices. J Cell Biol (1986) 103:2619-2627.
38. Brown EJ: Phagocytosis. BioEssays (1995) 17:109-117.
39. Colin M, Moritz S, Fontanges P, Kornprobst M, Delouis C, Keller M, Miller AD, Capeau J, Coutelle C, Brahimi-Horn MC: The nuclear pore complex is involved in nuclear transfer of plasmid DNA condensed with an oligolysine-RGD peptide containing nuclear localisation properties. Gene Ther (2001) 8:1643-1653.
40. Chen WJ, Goldstein JL, Brown MS: NPXY, a sequence often found in cytoplasmic tails, is required for coated pitmediated internalization of the low density lipoprotein receptor. J Biol Chem (1990) 265:3116-3123.
41. Zhang F, Andreassen P, Fender P, Geissler E, Hernandez JF, Chroboczek J: A transfecting peptide derived from adenovirus fiber protein. Gene Ther (1999) 6:171-181.
42. Carlisle RC, Bettinger T, Ogris M, Hale S, Mautner V, Seymour LW: Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectors. Mol Therapy (2001) 4:473-483.
43. Keller M, Tagawa T, Preuss M, Miller AD: Biophysical characterization of the DNA binding and condensing properties of adenoviral core peptide mu. Biochemistry (2002) 41:652-659.
44. Murray KD, Etheridge CJ, Shah SI, Matthews DA, Russell W, Gurling HM, Miller AD: Enhanced cationic liposome-mediated transfection using the DNA-binding peptide mu (mu) from the adenovirus core. Gene Ther (2001) 8:453-460.
45. Tagawa T, Manvell M, Brown N, Keller M, Perouzel E, Murray KD, Harbottle RP, Tecle M, Booy F, Brahimi-Horn MC, Coutelle C et al: Characterisation of LMD virus-like nanoparticles; self-assembled from cationic liposomes, adenovirus core peptide mu and plasmid DNA. Gene Ther (2002) 9:564-576.